Acumen Pharmaceuticals Plans To File A Preliminary Prospectus Supplement With The SEC For A Proposed Offering Of Common Stock, And As Of June 30, 2023, The Company Had Approximately $172.2M In Cash And Marketable Securities
Happy Mohamed - Jul 17, 2023, 4:50PM